JosephNicholasBodorMD

PubMed

• 6 citations
  Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy.
  J Nicholas Bodor, Jessica R Bauman, Elizabeth A Handorf, Eric A Ross, Margie L Clapper, Joseph Treat> ;Journal of Cancer Research and Clinical Oncology. 2023 May 1
• 5 citations
  Molecular characterization of Kita-Kyushu lung cancer antigen (KK-LC-1) expressing carcinomas.
  Robert Hsu, Yasmine Baca, Joanne Xiu, Rongfu Wang, J Nicholas Bodor, Chul Kim, Hina Khan, Hirva Mamdani, Misako Nagasaka, Sonam Puri, Stephen V Liu, W Michael Korn, Jo...> ;Oncotarget. 2021 Dec 7
• 1 citations
  Estimating Recurrence Risk in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer
  Christopher D’Avella, J. Nicholas Bodor> ;JAMA Network Open. 2021 Nov 1
• 72 citations
  Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.
  Mohamed E. Salem, J. Nicholas Bodor, Alberto Puccini, Joanne Xiu, Richard M. Goldberg, Axel Grothey, W. Michael Korn, Anthony F. Shields, William M Worrilow, Edward S....> ;International Journal of Cancer. 2020 Nov 15
• Corrigendum to "Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans ver...
  J. Nicholas Bodor, Josephine Feliciano, Martin J. Edelman> ;Lung Cancer. 2019 Sep 5
• Join now to see all

Lectures

• Pathogenic somatic mutation (SM) of mismatch repair (MMR) genes and associations with microsatellite instability (MSI), tumor mutational burden (TMB) and SM in other D... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018